RAPAFUSYN Trademark

Trademark Overview

On Thursday, October 1, 2015, a trademark application was filed for RAPAFUSYN with the United States Patent and Trademark Office. The USPTO has given the RAPAFUSYN trademark a serial number of 86775141. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, May 3, 2023. This trademark is owned by Rapafusyn Pharmaceuticals, Inc.. The RAPAFUSYN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

development of pharmaceutical preparations and medicines; laboratory research services relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical research and development; pharmaceutical research services
rapafusyn

General Information

Serial Number86775141
Word MarkRAPAFUSYN
Filing DateThursday, October 1, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, May 3, 2023
Registration Number5251736
Registration DateTuesday, July 25, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 1, 2016

Trademark Statements

Goods and Servicesdevelopment of pharmaceutical preparations and medicines; laboratory research services relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical research and development; pharmaceutical research services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 6, 2015
Primary Code042
First Use Anywhere DateMonday, April 24, 2017
First Use In Commerce DateMonday, April 24, 2017

Trademark Owner History

Party NameRapafusyn Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGrand Cayman KY1-1106
KY
Party NameRapafusyn Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGrand Cayman KY1-1104
KY
Party NameRapafusyn Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGrand Cayman KY1-1104
KY

Trademark Events

Event DateEvent Description
Wednesday, May 3, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, May 3, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, May 3, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, October 22, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, July 25, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, April 20, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 20, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 20, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 6, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 6, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 6, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 25, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, June 20, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, June 19, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 2, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 1, 2017STATEMENT OF USE PROCESSING COMPLETE
Monday, April 24, 2017USE AMENDMENT FILED
Monday, May 1, 2017SOU EXTENSION 2 GRANTED
Monday, April 24, 2017SOU EXTENSION 2 FILED
Monday, May 1, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 24, 2017TEAS EXTENSION RECEIVED
Monday, April 24, 2017TEAS STATEMENT OF USE RECEIVED
Saturday, October 22, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 20, 2016SOU EXTENSION 1 GRANTED
Thursday, October 20, 2016SOU EXTENSION 1 FILED
Thursday, October 20, 2016TEAS EXTENSION RECEIVED
Friday, July 22, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 26, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 1, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 1, 2016PUBLISHED FOR OPPOSITION
Wednesday, February 10, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 21, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 21, 2016ASSIGNED TO EXAMINER
Tuesday, October 6, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 5, 2015NEW APPLICATION ENTERED

Related Keywords

rapafusyn pharmaceutical research services development pharmaceuticals drug relating laboratory preparations medicines